145 related articles for article (PubMed ID: 6861434)
21. Lidocaine and its active metabolites.
Narang PK; Crouthamel WG; Carliner NH; Fisher ML
Clin Pharmacol Ther; 1978 Dec; 24(6):654-62. PubMed ID: 710024
[TBL] [Abstract][Full Text] [Related]
22. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
Huang YS; Lee SD; Deng JF; Wu JC; Lu RH; Lin YF; Wang YJ; Lo KJ
J Hepatol; 1993 Aug; 19(1):140-7. PubMed ID: 8301034
[TBL] [Abstract][Full Text] [Related]
23. Propofol does not inhibit lidocaine metabolism during epidural anesthesia.
Nakayama S; Miyabe M; Kakiuchi Y; Inomata S; Osaka Y; Fukuda T; Kohda Y; Toyooka H
Anesth Analg; 2004 Oct; 99(4):1131-1135. PubMed ID: 15385363
[TBL] [Abstract][Full Text] [Related]
24. Lidocaine plasma concentrations following administration of intraoral lidocaine solution.
Greenblatt DJ; Benjamin DM; Willis CR; Harmatz JS; Zinny MA
Arch Otolaryngol; 1985 May; 111(5):298-300. PubMed ID: 3985850
[TBL] [Abstract][Full Text] [Related]
25. Penetration of lidocaine and its active desethylated metabolite into cerebrospinal fluid in man.
Laurikainen E; Marttila R; Lindberg R; Kanto J
Eur J Clin Pharmacol; 1983; 25(5):639-41. PubMed ID: 6662163
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacokinetics of lidocaine and its metabolites in dog. Comparison between normal and CCl4-induced hepatic lesion].
Yamane J
Nichidai Koko Kagaku; 1989 Sep; 15(3):183-95. PubMed ID: 2489793
[TBL] [Abstract][Full Text] [Related]
27. Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.
Powell JR; Foster J; Patterson JH; Cross R; Wargin W
Clin Pharm; 1986 Dec; 5(12):993-8. PubMed ID: 3802729
[TBL] [Abstract][Full Text] [Related]
28. Comparison of five commonly-available, lidocaine-containing topical anesthetics and their effect on serum levels of lidocaine and its metabolite monoethylglycinexylidide (MEGX).
Oni G; Brown S; Kenkel J
Aesthet Surg J; 2012 May; 32(4):495-503. PubMed ID: 22452841
[TBL] [Abstract][Full Text] [Related]
29. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.
Orlando R; Piccoli P; De Martin S; Padrini R; Floreani M; Palatini P
Clin Pharmacol Ther; 2004 Jan; 75(1):80-8. PubMed ID: 14749694
[TBL] [Abstract][Full Text] [Related]
30. Monoethylglycinexylide formation in assessing pediatric donor liver function.
Rossi SJ; Schroeder TJ; Vine WH; A-Kader HH; Gremse DA; Ryckman FC; Pedersen SH; Pesce AJ; Balistreri WF
Ther Drug Monit; 1992 Dec; 14(6):452-6. PubMed ID: 1485364
[TBL] [Abstract][Full Text] [Related]
31. The use of the lidocaine-monoethylglycinexylidide test in the liver transplant recipient.
Potter JM; Hickman PE; Henderson A; Balderson GA; Lynch SV; Strong RW
Ther Drug Monit; 1996 Aug; 18(4):383-7. PubMed ID: 8857555
[TBL] [Abstract][Full Text] [Related]
32. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H
Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332
[TBL] [Abstract][Full Text] [Related]
33. Plasma concentrations of lidocaine and its principal metabolites during intermittent epidural anesthesia.
Inoue R; Suganuma T; Echizen H; Ishizaki T; Kushida K; Tomono Y
Anesthesiology; 1985 Sep; 63(3):304-10. PubMed ID: 4025891
[TBL] [Abstract][Full Text] [Related]
34. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence polarization immunoassay and HPLC assays compared for measuring monoethylglycinexylidide in liver-transplant patients.
Chen Y; Potter JM
Clin Chem; 1992 Dec; 38(12):2426-30. PubMed ID: 1458579
[TBL] [Abstract][Full Text] [Related]
36. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
Davison R; Parker M; Atkinson AJ
Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
Burdelski M; Schütz E; Nolte-Buchholtz S; Armstrong VW; Oellerich M
Ther Drug Monit; 1996 Aug; 18(4):378-82. PubMed ID: 8857554
[TBL] [Abstract][Full Text] [Related]
38. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
[TBL] [Abstract][Full Text] [Related]
39. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
Kupcová V; Turecký L; Szántová M; Schmidtová K
Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
[TBL] [Abstract][Full Text] [Related]
40. Lidocaine elimination and monoethylglycinexylidide formation in the dehydrated camel.
Ben-Zvi Z; Goldin G; Van Creveld C; Yagil R
J Vet Pharmacol Ther; 1995 Dec; 18(6):442-5. PubMed ID: 8789697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
